Method of detecting axonally-derived protein tau in patients with traumatic CNS injury

Method of detecting axonally-derived protein tau in patients with traumatic CNS injury

The present invention is in the field of clinical and diagnostic testing, and relates generally to a method of detecting axonal damage and associated disease states. Patients having several neurological diseases have been shown to have elevated levels of axonally-derived proteins (i.e. tau and neuro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Zemlan, Frank P
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Zemlan, Frank P
description The present invention is in the field of clinical and diagnostic testing, and relates generally to a method of detecting axonal damage and associated disease states. Patients having several neurological diseases have been shown to have elevated levels of axonally-derived proteins (i.e. tau and neurofilament proteins) in cerebrospinal fluid (CSF) and in brain tissue. Three monoclonal antibodies (MAbs) recognizing CSF tau proteins were developed. The MAbs were found to label a ladder of 30 kD to 50 kD tau proteins in CSF from patients with disease states producing axonal damage such as head trauma or CNS tumor but not in CSF from controls. High levels of tau protein in CSF were shown to be diagnostic of axonal degeneration in head trauma. An ELISA assay was developed with these MAbs to aid in the diagnosis of patients with axonal damage.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06589746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06589746</sourcerecordid><originalsourceid>FETCH-uspatents_grants_065897463</originalsourceid><addsrcrecordid>eNrjZAjzTS3JyE9RyE9TSEktSU0uycxLV0isyM9LzMmp1E1JLcosS01RKCjKL0nNzFMoSSxVAFIFiSWZqXklxQrlmSUZCiVFiaW5QJFkBWe_YKB0VmlRJQ8Da1piTnEqL5TmZlBwcw1x9tAtLQZqBumNTy9KBFEGZqYWluYmZsZEKAEA4446nw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Method of detecting axonally-derived protein tau in patients with traumatic CNS injury</title><source>USPTO Issued Patents</source><creator>Zemlan, Frank P</creator><creatorcontrib>Zemlan, Frank P ; University of Cincinnati</creatorcontrib><description>The present invention is in the field of clinical and diagnostic testing, and relates generally to a method of detecting axonal damage and associated disease states. Patients having several neurological diseases have been shown to have elevated levels of axonally-derived proteins (i.e. tau and neurofilament proteins) in cerebrospinal fluid (CSF) and in brain tissue. Three monoclonal antibodies (MAbs) recognizing CSF tau proteins were developed. The MAbs were found to label a ladder of 30 kD to 50 kD tau proteins in CSF from patients with disease states producing axonal damage such as head trauma or CNS tumor but not in CSF from controls. High levels of tau protein in CSF were shown to be diagnostic of axonal degeneration in head trauma. An ELISA assay was developed with these MAbs to aid in the diagnosis of patients with axonal damage.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6589746$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64015</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6589746$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Zemlan, Frank P</creatorcontrib><creatorcontrib>University of Cincinnati</creatorcontrib><title>Method of detecting axonally-derived protein tau in patients with traumatic CNS injury</title><description>The present invention is in the field of clinical and diagnostic testing, and relates generally to a method of detecting axonal damage and associated disease states. Patients having several neurological diseases have been shown to have elevated levels of axonally-derived proteins (i.e. tau and neurofilament proteins) in cerebrospinal fluid (CSF) and in brain tissue. Three monoclonal antibodies (MAbs) recognizing CSF tau proteins were developed. The MAbs were found to label a ladder of 30 kD to 50 kD tau proteins in CSF from patients with disease states producing axonal damage such as head trauma or CNS tumor but not in CSF from controls. High levels of tau protein in CSF were shown to be diagnostic of axonal degeneration in head trauma. An ELISA assay was developed with these MAbs to aid in the diagnosis of patients with axonal damage.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZAjzTS3JyE9RyE9TSEktSU0uycxLV0isyM9LzMmp1E1JLcosS01RKCjKL0nNzFMoSSxVAFIFiSWZqXklxQrlmSUZCiVFiaW5QJFkBWe_YKB0VmlRJQ8Da1piTnEqL5TmZlBwcw1x9tAtLQZqBumNTy9KBFEGZqYWluYmZsZEKAEA4446nw</recordid><startdate>20030708</startdate><enddate>20030708</enddate><creator>Zemlan, Frank P</creator><scope>EFH</scope></search><sort><creationdate>20030708</creationdate><title>Method of detecting axonally-derived protein tau in patients with traumatic CNS injury</title><author>Zemlan, Frank P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_065897463</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Zemlan, Frank P</creatorcontrib><creatorcontrib>University of Cincinnati</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Zemlan, Frank P</au><aucorp>University of Cincinnati</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Method of detecting axonally-derived protein tau in patients with traumatic CNS injury</title><date>2003-07-08</date><risdate>2003</risdate><abstract>The present invention is in the field of clinical and diagnostic testing, and relates generally to a method of detecting axonal damage and associated disease states. Patients having several neurological diseases have been shown to have elevated levels of axonally-derived proteins (i.e. tau and neurofilament proteins) in cerebrospinal fluid (CSF) and in brain tissue. Three monoclonal antibodies (MAbs) recognizing CSF tau proteins were developed. The MAbs were found to label a ladder of 30 kD to 50 kD tau proteins in CSF from patients with disease states producing axonal damage such as head trauma or CNS tumor but not in CSF from controls. High levels of tau protein in CSF were shown to be diagnostic of axonal degeneration in head trauma. An ELISA assay was developed with these MAbs to aid in the diagnosis of patients with axonal damage.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_06589746
source USPTO Issued Patents
title Method of detecting axonally-derived protein tau in patients with traumatic CNS injury
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T22%3A54%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Zemlan,%20Frank%20P&rft.aucorp=University%20of%20Cincinnati&rft.date=2003-07-08&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06589746%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true